Regenerative Ocular Immunobiologics LLC
2 clinical trials · Sponsor
◉ Watch Regenerative Ocular Immunobiologics LLC
| Record | Firm | Date |
|---|---|---|
| Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) (NCT06852768) | Regenerative Ocular Immunobiologics LLC | 2025-01-10 |
Track Regenerative Ocular Immunobiologics LLC automatically
Every clearance here is in the API, with alerts when new ones post.